ArticlePharmaceuticals (Basel, Switzerland)2023

The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease.

Sabrina Schnur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.